Pharmacy Podcast Network

On this week’s This Week in Pharmacy (TWIRx), we explore how innovation, technology, and emerging therapies are reshaping pharmacy practice. From the growing influence of AI in medical information research, to the next generation of pharmacy management systems, and the expanding role of cell and gene therapies, this episode brings together industry leaders to discuss what’s next for pharmacy. Special thanks to this week’s sponsors Cardinal Health, Independent Pharmacy Cooperative (IPC), and Nested Knowledge for supporting the podcast. Segment 1 – AI & the Future of Medical Information with Nested Knowledge Nested Knowledge returns to TWIRx as we welcome back Keith Kallmes, Co-Founder of Nested Knowledge, for an update on how artificial intelligence is transforming the way healthcare professionals access and interpret medical information. Keith explains how AI-powered tools are improving evidence synthesis, systematic literature reviews, and clinical decision support, helping researchers and clinicians navigate the growing volume of medical literature while enabling faster, more reliable insights. Segment 2 – The Evolution of Pharmacy Management Systems with Outcomes Next, we’re joined by Lou Ann Myers from Outcomes to discuss how pharmacy management systems are evolving beyond traditional dispensing. Modern pharmacies require integrated technology connecting billing, treatment planning, clinical tracking, inventory management, and revenue-generating services. Lou Ann shares why these systems must support both clinical services and business sustainability as pharmacies expand into value-based care and new service models. Segment 3 – Emerging Therapies with Cardinal Health In our final segment, we welcome Dr. Fran Gregory, PharmD, Vice President of Emerging Therapies (Cell & Gene, Biosimilars) at Cardinal Health, to discuss one of the most transformative areas in healthcare. Dr. Gregory explores the growing impact of cell and gene therapies and biosimilars, and what these innovations mean for pharmacists, health systems, and specialty pharmacy providers as the industry prepares for new challenges in distribution, access, and reimbursement. About TWIRx (This Week in Pharmacy) TWIRx is the flagship news and commentary podcast from the Pharmacy Podcast Network, delivering weekly insights on the business, technology, and policy shaping the pharmacy profession.

In this inspiring episode of CPhT Connect, host Mike Johnston, CPhT-Adv, sits down with Ellaine Sisomphou-Ramos, a nationally certified pharmacy technician whose career is a masterclass in professional growth and self-advocacy. Originally trained as a nurse in the Philippines, "Ella" shares her remarkable journey of transitioning to the U.S. pharmacy landscape, moving from high-volume retail to a specialized role in outpatient infusion and specialty pharmacy. Her dedication to clinical excellence recently earned her a nomination as one of the Top 50 Most Influential Leaders in The Pharmacy 50 Awards by Pharmacy Podcast Network, where she ranked in the top 45—a powerful testament to the impact a technician can have on the entire profession.

Dental care during pregnancy is often overlooked in routine prenatal counseling, yet hormonal changes, frequent vomiting, dehydration, and acid exposure can significantly impact oral health in pregnancy. In this episode of the MaternalRx Podcast, host Dr. Danielle Plummer, PharmD speaks with Dr. Michael Duboff, DMD, about the critical importance of dental care during pregnancy and how pharmacists and healthcare providers can help prevent long-term complications. From enamel erosion caused by hyperemesis gravidarum to pregnancy gingivitis and periodontal disease, this conversation explores what happens inside the mouth during pregnancy, when tooth damage becomes irreversible, and what practical steps patients and healthcare providers can take to protect oral health. Dr. Duboff also addresses common misconceptions about the safety of dental treatment during pregnancy, including fluoride use, dental X-rays, anesthetics, and the importance of preventive dental care. The episode also highlights insurance and access issues, including how some insurance plans and Medicaid programs may expand dental coverage during pregnancy, an important opportunity for patients to receive needed care. This episode emphasizes the critical role pharmacists can play in maternal health education, early identification of oral health risks, and patient counseling. You'll Learn: • How repeated gastric acid exposure from vomiting can weaken tooth enamel during pregnancy • Why brushing immediately after vomiting can worsen enamel erosion • Safe oral care strategies for pregnant patients with severe nausea or hyperemesis gravidarum • What pregnancy gingivitis is and why hormonal changes increase gum inflammation and bleeding • How fluoride varnish and high-fluoride toothpaste help protect enamel during pregnancy • Why dental cleanings every 3 months may benefit pregnant patients • The link between periodontal disease and adverse pregnancy outcomes, including preterm birth and low birth weight • Why dental treatment—including X-rays and local anesthetics—is generally safe during pregnancy • Restorative treatment options for enamel erosion and tooth decay, including fillings, crowns, and bonding • How insurance coverage and Medicaid policies may provide expanded dental benefits during pregnancy • The important role pharmacists can play in oral health counseling for pregnant patients Key Clinical Takeaways 1. Gastric Acid Damages Tooth Enamel Frequent vomiting exposes teeth to stomach acid, which erodes enamel and exposes the underlying dentin, increasing the risk of decay and sensitivity. 2. Do NOT Brush Immediately After Vomiting Brushing immediately after vomiting can scrub away weakened enamel. Instead: Rinse with water or a baking soda solution Wait about 30 minutes before brushing 3. Pregnancy Increases Risk of Gingivitis Hormonal changes during pregnancy increase gum inflammation and bleeding, making good oral hygiene and professional cleanings even more important. 4. Dental Care During Pregnancy Is Safe Preventive care and many dental treatments—including dental X-rays with shielding and local anesthetics—are considered safe, particularly during the second trimester. 5. Preventive Care Is Essential Regular dental visits, fluoride treatments, and proper oral hygiene can help prevent irreversible enamel damage and periodontal disease. 6. Insurance Coverage May Improve During Pregnancy Some insurance plans and Medicaid programs expand dental coverage for pregnant patients, providing an important opportunity to receive preventive care and necessary dental treatment. Practical Counseling Tips for Pharmacists Pharmacists can support pregnant patients by recommending: • Rinsing with water or baking soda solution after vomiting • Waiting 30 minutes before brushing teeth • Using fluoride toothpaste or prescription high-fluoride toothpaste if appropriate • Maintaining hydration whenever possible • Scheduling regular dental visits during pregnancy • Seeking evaluation for bleeding gums, tooth sensitivity, or oral pain Because pharmacists are often the most accessible healthcare professionals, they play an important role in identifying oral health risks early and encouraging patients to seek dental care. Connect With Our Guests Dr. Michael Duboff, DMD Practice: AXIS Dental – Las Vegas Email: SmileDesignersLV@yahoo.com Dr. Danielle Plummer, PharmD Website: www.Obstet-Rx.com LinkedIn: https://www.linkedin.com/in/daniellerplummer/

Welcome to PPN – The Precision Medicine Pharmacist, the podcast where science, innovation, and collaboration are redefining patient care. We are kicking off a special two-part series titled Precision Psychiatry in Practice – A Pharmacist–Physician Collaboration. In this series, we explore how precision medicine is reshaping mental health treatment — and what becomes possible when pharmacists and psychiatrists work together with shared clinical goals. Today’s episode, The New Frontier: How Pharmacists and Psychiatrists Are Teaming Up for Precision Mental Health, focuses on how this collaboration began — the challenges that inspired it, the early conversations that shaped it, and the practical steps taken to bring pharmacogenomics into psychiatric care. Joining us is Dr. Saba Arshad, clinical pharmacist, founder of Med DNA Health, and a strong advocate for integrating pharmacogenomic insight into mental health treatment. We will also hear from Dr. Afshan Khan, psychiatrist and clinical partner in this model of care, as we explore how their professional paths aligned to create something new. In this first episode, we will lay the foundation — examining the “why” behind precision psychiatry and the systems that had to evolve to support it. Then, in part two, Dr. Khan will join us more extensively as we move from framework to real-world impact, sharing patient cases, clinical outcomes, and lessons learned from implementing precision medicine in practice.

Welcome back to season 9! We’re kicking it off with my first powerhouse guest, whose mission is to bring clarity, safety, and evidence-based understanding to hyperbaric oxygen therapy and integrative wellness. There is a growing wave of interest in longevity and recovery therapies, but also a lot of confusion and misinformation. She breaks down the science (and safety) of one of the most powerful, foundational tools we have for reducing inflammation, accelerating healing, and supporting long-term health.  Nicole Garrett is the CEO of Under Pressure Hyperbarics, a premier hyperbaric oxygen therapy center in Beverly Hills recognized for its clinical-grade safety standards and results-driven approach to wellness. With nearly two decades of experience in hyperbaric medicine, her career began as a commercial diver and dive medic, where she first learned the life-saving applications of pressure and oxygen in extreme environments. Since then, Nicole has helped open and operate HBOT centers across the country and has become a trusted leader in the field. Her work bridges the gap between medical-grade hyperbaric therapy and modern holistic wellness, offering patients a safe and effective path to healing, recovery, and long-term vitality. Nicole is especially passionate about educating clinicians, patients, and the wellness community on the science, indications, and proper protocols behind hyperbaric therapy. Today, she leads a multidisciplinary team at Under Pressure Hyperbarics that supports surgical recovery, sports performance, chronic inflammation, and overall health optimization using hospital-grade chambers and evidence-aligned treatment plans. Connect with Nicole via: Email: nicole@underpressure.com  Website: Under Pressure Hyperbarics FB: Under Pressure Hyperbarics IG: @underpressurehyperbarics Linked In: Under Pressure Hyperbarics

Welcome to this special three-part press coverage series from the Pharmacy Podcast Network, recorded on location at the Pennsylvania Pharmacists Association Annual Conference, held February 20th through the 22nd at the Hilton Harrisburg. This series is proudly sponsored by Value Drug Company and the Pennsylvania Pharmacists Care Network — PPCN — as they celebrate their 10th anniversary of advancing pharmacist-led patient care across the Commonwealth.   In this episode we hear from: Margie Lydon - Value Drug Company Darren Mensch, PharmD, BCPS, BCACP Hayleigh Monroe - P4 Pharmacy Student Mayank (Dr. Mak) Amin, PharmD, RPh, MBA  Todd Laser - Value Drug Company Jonathan Adly - TJM Labs  Jennifer (Pekich) Urso

Welcome to another episode of TWIRx – This Week in Pharmacy, where we break down the most important developments impacting the pharmacy profession. This week’s show features leaders from across community pharmacy, health systems, healthcare advocacy, and international patient engagement. From PBM reform to patient-centered care and health system growth in Western Pennsylvania, this episode brings together voices shaping the future of pharmacy. Sponsored by Sykes & Company, P.A. Accounting, tax strategy, and advisory services dedicated exclusively to independent pharmacy operators. Segment 1 Austin Murray Communications and Marketing Director – Sykes & Company, P.A. We kick off TWIRx with Austin Murray from Sykes & Company, discussing the NCPA Consumer Marketing Campaign designed to educate the public about the value of community pharmacies. Austin shares insights on: • The importance of telling the community pharmacy story directly to consumers • Why independent pharmacies remain essential healthcare access points • The evolving state of independent pharmacy nationwide • Continued momentum around PBM Reform • Strategic accounting and tax advantages pharmacy operators should understand in today’s challenging reimbursement environment Austin also explains how pharmacy-focused accounting firms like Sykes & Company help owners navigate reimbursement pressure, tax planning, and business strategy. Segment 2 Mark Duman Pharmacy 50 Award Winner – United Kingdom International healthcare thought leader Mark Duman joins TWIRx to discuss one of the most important principles in healthcare transformation: The patient must come first. Mark shares his perspective on: • Why healthcare systems must remain patient-centered • How pharmacy can lead the way in improving patient outcomes • Lessons learned from patient engagement initiatives in the UK healthcare system • Why meaningful healthcare innovation always begins by focusing on the patient experience Mark emphasizes that when healthcare professionals keep the patient as the constant focus, better pharmacy care and stronger health systems follow. Segment 3 Dr. Laura Mark, PharmD Vice President of Pharmacy – Allegheny Health Network Next, we welcome Dr. Laura Mark, Vice President of Pharmacy at Allegheny Health Network (AHN), who shares exciting news about new pharmacy operations facilities recently built in Butler County, Pennsylvania. Todd and Laura also reflect on their shared roots growing up in Butler County, while discussing how AHN is investing in the future of pharmacy. Topics include: • The new pharmacy operations infrastructure in Western Pennsylvania • How AHN is expanding pharmacy services across the Greater Pittsburgh region • The role of health system pharmacy in improving access to care • Strategic positioning for future healthcare growth and integration AHN continues to strengthen its pharmacy operations as a key component of coordinated patient care throughout the region. Segment 4 Eric Pusey Independent Pharmacy Owner – Pennsylvania Closing out this week’s episode, pharmacy owner Eric Pusey joins TWIRx to discuss the latest updates on PBM Reform in Pennsylvania. In 2024, Pennsylvania enacted Act 77, a landmark law aimed at increasing oversight and fairness in pharmacy benefit management. Eric explains how the law: • Grants new regulatory authority to the Pennsylvania Insurance Department • Restricts PBM patient steering to pharmacies owned or affiliated with benefit managers • Improves transparency requirements for PBM operations • Establishes payment protections intended to level the playing field for community pharmacies Patient steering practices have long limited competition and reduced patient choice. Eric shares why these reforms represent an important step toward protecting both patients and independent pharmacy providers across the Commonwealth. Listen & Subscribe Stay informed on the business, policy, and innovation shaping the pharmacy profession. Follow TWIRx – This Week in Pharmacy on the Pharmacy Podcast Network, featuring conversations with the leaders and advocates advancing pharmacy practice.

In this episode, listeners get to know the leadership of the California Pharmacists Association (CPhA), exploring their professional journeys, personal backgrounds, and the experiences that shaped their commitment to advancing the pharmacy profession. Susan Bonilla, CEO of the California Pharmacists Association, joins Dr. Sean Kim, PharmD, Vice President of Practice & Professional Development at CPhA, to discuss California’s progress in pharmacy benefit manager (PBM) reform. As the largest state in the nation, California continues to play a significant role in shaping policies that strengthen patient access to pharmacy care and improve transparency within the prescription drug supply chain. Bonilla and Kim share insights into the reforms California has achieved, the legislative and regulatory priorities currently underway, and how these efforts may influence PBM reform conversations across the country. The PBM Reform Podcast is sponsored by the American Pharmacy Cooperative, Inc. (APCI). APCI’s sponsorship supports the production of this program but does not imply affiliation with the individual guests, nor endorsement of the views, opinions, or insights shared by podcast hosts or guests. APCI does not endorse any statements or content discussed on the PBM Reform Podcast or across the Pharmacy Podcast Network. Please reach out to the APCI Communication's team for additional information. 

In this edition of Essential, we look at two major issues facing pharmacy compounding. First is a state-by-state effort by pharma companies to pass laws restricting compounding, and second is a cryptic statement from the FDA about  possible limitations on compounding with GLP-1 ingredients. They’re both Very Big Deals for pharmacists across the country. Links FDA statement on GLP-1 drugs: https://www.fda.gov/news-events/press-announcements/fda-intends-take-action-against-non-fda-approved-glp-1-drugs … and APC’s response: https://a4pc.org/news/apc-responds-to-fdas-glp-1-statement  Stay up to date on our state Compounding Defense Initiative: compounding.com  Join APC today: https://a4pc.org/membership  Find us on social: LinkedIn: https://www.linkedin.com/company/a4pcrx/ Facebook: https://www.facebook.com/a4pcrx/ Instagram: https://www.instagram.com/a4pcrx/

In this episode of Framework Focus, Dr. Dae Lee breaks down the regulatory and reimbursement shifts reshaping long-term care (LTC) pharmacy. With the Inflation Reduction Act (IRA) moving from policy theory to operational reality, Medicare’s Maximum Fair Price (MFP) program, Part D redesign, and inflation rebate enforcement are now active forces that LTC operators must navigate. This conversation moves beyond headlines and into real-world implications: cash flow risk, administrative burden, contracting exposure, and strategic readiness for closed-door and combo LTC pharmacies. Key Discussion Points Medicare Drug Price Negotiation Is Now Operational  The IRA authorizes Medicare to negotiate prices for certain high-spend Part D drugs, with the first 10 Maximum Fair Prices (MFPs) effective January 1, 2026. This marks a structural shift in federal drug pricing and directly impacts LTC dispensing economics. Maximum Fair Price and LTC Reimbursement Compression  MFP caps reimbursement on selected drugs, creating potential margin compression if acquisition costs and payment timing are misaligned. For LTC pharmacies operating on tight spreads and high-volume chronic utilization, even small deltas can materially affect profitability. Medicare Transaction Facilitator (MTF) and Payment Timing Risk  The MTF system introduces new payment mechanics between manufacturers, plans, and pharmacies. LTC pharmacies must understand how effectuation and reconciliation work, particularly if payment timing differs from traditional Part D adjudication flows. Cash flow modeling becomes essential. Administrative Complexity and Claims Reconciliation  Identifying which NDCs are subject to MFP, managing claim reversals, handling price disputes, and monitoring plan-level compliance will increase administrative workload. LTC pharmacies will need structured internal workflows to prevent reimbursement leakage. Dispensing Fees and the LTC Service Intensity Problem  Unlike retail, LTC pharmacy includes compliance packaging, emergency kits, cycle fills, consultant pharmacist oversight, and regulatory documentation. Current IRA implementation does not automatically adjust dispensing or supply fees to reflect this complexity, raising sustainability concerns. Congressional Efforts to Stabilize LTC Pharmacy  Legislative proposals such as the Preserving Patient Access to LTC Pharmacies Act aim to create supply fee protections tied to MFP drugs. The episode explores whether policy corrections are likely — and how quickly DC can realistically respond. Expansion of Negotiated Drug Lists  The initial 10 negotiated drugs are only the beginning. Additional rounds of negotiation are underway, expanding exposure across more therapeutic classes. LTC pharmacies must treat MFP as a growing structural feature — not a limited pilot. Part D Redesign and the $2,100 Out-of-Pocket Cap  Beginning in 2026, the redesigned Part D benefit changes liability distribution among plans, manufacturers, and CMS. The new out-of-pocket cap alters plan incentives and may lead to tighter utilization management, formulary shifts, and network recalibration — all of which LTC pharmacies must monitor closely. Inflation Rebates and Market Distortion  The IRA’s inflation rebate provisions penalize manufacturers for price increases above inflation benchmarks. While not directly adjudicated at the pharmacy counter, these provisions influence manufacturer pricing strategy, launch pricing behavior, and downstream PBM negotiations — indirectly affecting LTC acquisition costs. Strategic Readiness as a Competitive Advantage  The episode concludes with practical recommendations:  • Conduct an MFP exposure audit across top-dispensed NDCs  • Reassess PBM contracts and network participation clauses  • Model cash flow under delayed reimbursement scenarios  • Educate facility partners on regulatory changes  • Build internal compliance tracking specific to negotiated drugs Why This Matters Now For LTC pharmacies, this is not simply a policy conversation — it is a structural shift in reimbursement architecture. As federal oversight expands and pricing authority evolves, operational precision and legal literacy will define which organizations adapt successfully. About our guest:  Dr. Dae Lee, Pharm.D, Esq., CPBS  Shareholder - Buchanan Ingersoll & Rooney PC  Email: dae.lee@bipc.com  Dae Y. Lee is a pharmacist-attorney and Certified Pharmacy Benefits Specialist™ (CPBS™) who represents pharmacies, healthcare stakeholders, and plan sponsors in high-stakes disputes and regulatory matters involving Pharmacy Benefit Managers (PBMs) and government payors. Drawing on his dual training as a pharmacist and attorney, Dae focuses his practice on defending clients in audits, investigations, enforcement actions and complex reimbursement and compliance matters. Dae routinely represents pharmacies nationwide in PBM and payor audits, including Fraud, Waste and Abuse (FWA) investigations, extrapolation disputes, overpayment recoupments, credentialing denials, network suspensions and terminations. He advises pharmacies on compliance with applicable state pharmacy fair audit laws, PBM provider manuals, and reimbursement standards, with the goal of minimizing financial exposure while preserving network participation and business continuity.

On this episode of This Week in Pharmacy, we spotlight two major conversations shaping the future of pharmacy practice in 2026. First, we welcome Dr. Lisa Faast, PharmD, founder of DiversifyRx, to discuss the Pharmacy Profit Summit 2026 and how independent pharmacies can strengthen margins, diversify revenue streams, and build sustainable growth models in today’s reimbursement environment. Then, we turn to Rare Disease Day 2026 with Richard Faris, PharmD, Chief Commercial & Clinical Officer at PANTHERx Rare, to discuss specialty pharmacy leadership, pharmacist impact, and new patient feedback data revealing communication gaps in rare disease care. Segment 1: Pharmacy Profit Summit 2026 Guest: Dr. Lisa Faast, PharmD | Founder, DiversifyRx Dr. Faast joins us to break down the vision behind Pharmacy Profit Summit 2026 — an event designed to equip pharmacy owners with practical strategies to increase profitability while maintaining clinical excellence. Key Topics Covered: • Why independent pharmacies must move beyond traditional dispensing revenue  • Diversification strategies including niche services and high-value offerings  • Real-world financial benchmarks pharmacy owners should track  • How mindset, leadership, and data discipline drive sustainable profitability  • The importance of collaboration and shared intelligence among pharmacy entrepreneurs The Pharmacy Profit Summit is not just about revenue — it’s about equipping pharmacy owners to compete intelligently in a rapidly consolidating healthcare market. Segment 2: Rare Disease Day 2026 Guest: Richard Faris, PharmD | PANTHERx Rare Pharmacy In recognition of Rare Disease Day 2026, we are honored to welcome Richard Ferris, PharmD, to discuss the critical role pharmacists play in specialty pharmacy and rare disease care. PANTHERx Rare recently released survey findings examining patient and caregiver experiences within rare disease treatment journeys. Key Study Highlights: • 90% of patients and caregivers report delays due to communication gaps  • 68% report waiting for updates from providers, pharmacies, or insurers  • 90% say they manage the care process themselves  • 72% desire a dedicated care coordinator  • 73% agree it is unclear who is responsible for coordinating rare disease care Despite advances in specialty therapeutics, patients are still asking for the fundamentals: clear communication, coordinated care, and personalized support. Richard discusses: • The growing importance of specialty pharmacists as care coordinators  • Why rare disease patients often feel burdened by system fragmentation  • How specialty pharmacy can close communication gaps  • The need for pharmacist-led continuity in complex therapy management Rare Disease Day reminds us that specialty pharmacy is not only about high-cost medications — it is about human connection, long-term coordination, and advocacy for patients navigating some of the most complex clinical journeys in healthcare.  From business sustainability to patient-centered specialty care, this episode reinforces two realities: Pharmacy must remain financially strong to survive. Pharmacists must remain clinically present to lead. As the profession evolves, profitability and patient advocacy are not opposing forces — they are interdependent pillars of pharmacy’s future. Listen now and join the conversation shaping Pharmacy in 2026.

Many pharmacy owners invest in expensive technology but fail to fully utilize the system’s secondary and valuable features. This is a costly mistake!  It leaves significant operational efficiencies and profit opportunities unrealized. This program also invites managers to carefully review their tech vendor invoices to ensure new charges have not been added or that fees have not been quietly increased for features in their software agreements. Kevin Minassian, President of DataScan, notes his company provides a wide range of profit-enhancing services at no additional cost while competitors often add additional fees. Visit www.datascanpharmacy.com for more information.

“Thug Drugs: Policy” THUG DRUGS! With a name like that, it has to be good! Even better than Smuckers (Age old ad slogan for jelly/jam)!  In this episode of the Pain Pod, we’re going to dive into Thug Drug Policies, here in our country, and beyond. Come one, come all, to the Pain Pod!!! www.painguy.us

Welcome back to the Pediatric Pharmacist Review Podcast. Today’s Pharmacist Spotlight features Brian Seyboth, a pediatric hematology/oncology pharmacist and the first full-time pharmacist at Perfecting Peds. In this episode, Brian shares a powerful patient care win that shaped his career and highlights why pediatric oncology pharmacy is both highly technical and deeply personal. We discuss how pharmacists optimize complex medication regimens, support families during difficult diagnoses, and improve outcomes through collaborative decision-making. Brian also reflects on mentoring residents, expanding pharmacist integration into pediatric care teams, and adapting clinical pharmacy services into a virtual environment. Whether you're a student, resident, or practicing clinician, this conversation shows how pharmacists can transform pediatric care through expertise and compassion. Let’s get started.

How Kroger does PBM and the future of community pharmacy is clinical encounters.

Rx4Route is a specialized pharmacy delivery management platform and software designed to optimize prescription delivery for pharmacies. It integrates with existing systems to provide real-time tracking, AI-powered route optimization, HIPAA-compliant proof of delivery, and driver management tools. It aims to reduce delivery costs and improve efficiency. Doni Sattarov with Rx4Route Rx4Route.com   Kristen Hutchison - Health Policy and Patient Advocacy As a seasoned medical technical writer and chronic illness patient advocate, I meticulously translate intricate medical information into succinct content tailored for diverse audiences, including engineers, clinicians, educators, and advocacy groups. https://www.khutchison.com/

Join us for an informational session where Lisa Schwartz joins Ketan Mehta to discuss how pharmacies can build the road to success in 2026 through industry hurdles, trends, and policy changes.

From reimbursements to inventory management, independent pharmacists face ongoing pressure to optimize the financial health of their business. In this episode, Jean Paul Gibeault, PharmD, RPh of Atlantic Health System shares how their two retail pharmacies have maintained strong financial performance using solutions like Cardinal Health™ Reimbursement Consulting Services (RCS). He discusses how real-time intelligence and a robust analytics and consulting platform can transform a pharmacy’s bottom line.  Listen to uncover financial strategies that can help boost revenue and expand patient reach while upholding an unwavering commitment to quality, community care. 

In this must-listen episode of MaternalRx, host Danielle Plummer, PharmD, sits down with Dr. Eboni January (AKA Dr. EJ), award-winning board-certified OBGYN, bestselling author, and America’s Maternal & Women’s Wellness Expert, to unpack what’s really driving the maternal mortality crisis in the U.S. With more than 8,000 babies delivered, Dr. EJ brings frontline clinical insight, cultural competence, and a prevention-first approach to a conversation that moves beyond headlines and into actionable change. Together, Dr. Plummer and Dr. EJ explore why most maternal deaths are preventable, what clinicians often miss, and how healthcare professionals, including pharmacists, can help save lives through earlier intervention, equity-focused care, and better patient education. Episode Highlights: - Why the U.S. has the highest maternal mortality rate among high-income countries - The reality that 80%+ of maternal deaths are preventable - Critical red flags during pregnancy and postpartum that should never be dismissed - Preventive conversations every woman deserves before pregnancy - How health equity shows up (or fails) in real-world clinical care - One pregnancy myth Dr. EJ is ready to retire for good About the Guest: Dr. Eboni January, MD (Dr. EJ) is a nationally recognized OB-GYN, maternal health advocate, and media expert. She is the author of three bestselling books, including Empowered Motherhood, and the founder of multiple women-centered wellness initiatives focused on maternal safety, preventive care, and whole-woman health. Connect with Dr. January: Website: www.doctorej.com Social: @doctorebonijanuary Connect with Danielle Plummer, PharmD:  www.linkedin.com/in/daniellerplummer/ www.Obstet-Rx.com Please subscribe, rate, and share MaternalRx. Elevating these conversations helps protect mothers and saves lives.

TWIRx – This Week in Pharmacy Episode Date: February 13, 2026 Valentine’s Day Special 💘 This week on TWIRx, hosts Stephen Beckman, PharmD and Todd Eury break down the biggest headlines shaping pharmacy, from workforce trends to policy updates and innovation. 💕 Valentine’s Feature: TogetheRx – A Pharmacy Love Story In celebration of Valentine’s Day, we welcome Drs. Mark and Gretchen Garofoli, PharmD, a pharmacy power couple who met at the University of Pittsburgh School of Pharmacy and have built a life and career TogetheRx. Their journey includes raising a family, leading in pharmacy advocacy, podcasting, academic work with WVU School of Pharmacy, and operating a community pharmacy near Morgantown, WV. 🧪 Love Potion Segment: A Historical Rx Dr. Mark Fulton, PharmD, host of the RxTales Podcast, joins the show to explore the surprising history of “love potions” and how folklore intersects with early pharmacy and medicine. 🚀 Innovation Spotlight: RxTransfer & Interoperability We close with Pharmacy 50 Award Winner Alumni 2025, Dr. Lawrence King, PharmD, VP of Product Innovation at Surescripts, discussing RxTransfer, prescription interoperability, and how technology is modernizing pharmacy workflow and patient safety. ❤️ From love stories to pharmacy innovation, this Valentine’s edition celebrates the profession from the heart. Subscribe, listen, and share as we head into Valentine’s Day 2026. Valentine’s Day Special 2026 | TWIRx